GlassScriptPhysician profile
Kenneth Scott Lloyd
NPI 1619985363
$33,204.15
in general payments reported to CMS, 2019-2025
39 companies · $490 in 2025
The $490 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,709 · 2020: $15K · 2021: $3,837 · 2022: $6,262 · 2023: $1,461 · 2024: $431 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,181 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,181.08 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $10,299.67 | 2020-2023 | Acthar |
| Glaxosmithkline, LLC. | $2,977.71 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $2,854.05 | 2019-2025 | Dupixent |
| Genzyme Corporation | $2,730.09 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $2,250.67 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Actelion Pharmaceuticals US, INC. | $2,105.41 | 2019-2023 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,908.27 | 2019-2023 | Ofev |
| United Therapeutics Corporation | $1,240.63 | 2019-2024 | Tyvaso, Orenitram |
| Mylan Specialty L.P. | $1,028.97 | 2019-2023 | Yupelri |
| Insmed, INC. | $783.22 | 2019-2024 | Arikayce |
| Bayer Healthcare Pharmaceuticals INC. | $562.24 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $487.80 | 2020-2023 | Cuvitru |
| Advanced Respiratory, INC | $438.59 | 2019-2021 | |
| Genentech USA, INC. | $399.43 | 2019-2021 | |
| Baxter Healthcare | $381.18 | 2022-2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $336.57 | 2020-2023 | Fetroja |
| Sunovion Pharmaceuticals INC. | $327.18 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $237.03 | 2019-2020 | |
| Zoll Respicardia, INC. | $213.25 | 2019 | |
| Mallinckrodt Enterprises LLC | $173.69 | 2019 | |
| Pfizer INC. | $170.75 | 2019-2023 | |
| Ani Pharmaceuticals, INC. | $145.02 | 2022-2023 | Purified Cortrophin Gel |
| Jazz Pharmaceuticals INC. | $141.88 | 2019-2021 | |
| Pulmonx Corporation | $128.25 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $123.76 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $121.86 | 2025 | Iqirvo |
| Shire North American Group INC | $108.84 | 2019 | |
| Circassia INC. | $68.89 | 2019-2020 | |
| Electromed, INC. | $67.15 | 2021 | |
| Resmed Corp | $61.70 | 2019 | |
| Gilead Sciences, INC. | $59.47 | 2019 | |
| Grifols USA, LLC | $49.79 | 2020-2022 | |
| Genentech, INC. | $47.95 | 2020 | |
| Paratek Pharmaceuticals, INC. | $44.61 | 2022-2023 | Nuzyra |
| Amgen INC. | $43.41 | 2022-2023 | Tezspire |
| E.R. Squibb & Sons, L.L.C. | $32.12 | 2020-2021 | |
| Itamar Medical INC | $18.78 | 2021 | |
| Inogen, INC. | $18.65 | 2022 | |
| Sanofi Pasteur INC. | $15.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.